Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
S63845 | MCL1 Inhibitor | MedChemExpress
S63845 - Selective MCL1 Inhibitor for Cancer Research | APExBIO
S63845 | MCL1 Inhibitor | TargetMol
S63845 | MCL1 Inhibitor | CAS 1799633-27-4 | Selleck Chemicals
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK ...
| S63845 binds to the BH3-binding groove of MCL1 and kills tumour cell ...
| S63845 is effective against haematological cancer-derived cell lines ...
Synergistic action of the MCL-1 inhibitor S63845 with current therapies ...
Signaling pathways underlying Trans Vaccenic acid(TVA) and/or S63845 ...
美国APExBIO中文官网 - S63845 | CAS# 1799633-27-4 | MCL1抑制剂
The selective MCL-1 inhibitor S63845 augments the senolytic effects of ...
S63845 | CAS# 1799633-27-4 | MCL1 inhibitor
S63845 strongly synergizes with venetoclax in killing T-ALL cells in ...
(PDF) The MCL1 inhibitor S63845 is tolerable and effective in diverse ...
Full article: AKT inhibition sensitizes acute leukemia cells to S63845 ...
S63845 binds MCL-1 and induces apoptosis in several cancer cell lines ...
Combinatorial action of IACS‐010759 and the Mcl‐1 inhibitor S63845 in ...
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and ...
S63845 is effective against SCLC with high MCL1 and low BCL-X L ...
Cisplatin and S63845 synergize in MDA-MB-468 cells. MDA-MB-468 cells ...
Combined S55746 and S63845 suppresses leukemia in vivo in NRG-SG3 ...
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 ...
Synergistic activity of venetoclax and S63845 in patient-derived ...
The Impact of Panobinostat on Cell Death in Combination with S63845 in ...
MCL-1 Inhibitor S63845 Distinctively Affects Intramedullary and ...
Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit ...
S63845 | CAS 1799633-27-4 | SCBT - Santa Cruz Biotechnology
| Synergy of trametinib and S63845 in NALM-6 is explained by an ...
Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 Synergizes with ...
S63845 is an efficient senolytic therapy in vivo a Schematic ...
Combination treatment with lapatinib and S63845 leads to antitumor ...
Ulixertinib and S63845 cooperate to reduce cell viability and ...
Metformin and MCL-1 inhibitor S63845 effect on cell apoptosis. Cell ...
Effects of S63845 on induction of apoptosis in BCP-ALL cell lines. a ...
Venetoclax and S63845 combine to inhibit tumor growth in vivo. Mice ...
| Inhibitory effect of venetoclax and S63845 on tumor cell lines ...
Down-regulation of c-Myc expression in presence of S63845 and ...
(PDF) Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 ...
| Trametinib synergizes with S63845 in NALM-6 cells, increasing BIM and ...
S63845 | BCL | TargetMol
Both navitoclax and S63845 induce autophagy and apoptosis in MEFs ...
Ulixertinib cooperates with S63845 to induce caspase-dependent cell ...
S63845 and venetoclax combine to decrease cell viability. A, Cell ...
S63845 combined with ABT-263 or A-1331852 killed the resistant ...
Venetoclax, alone and in combination with the BH3 mimetic S63845 ...
Reduction in hepatic fibrosis is sustained after treatment with S63845 ...
Synergic effect of S63845 with doxorubicin in acute lymphoblastic ...
S63845 combined with ABT-263 or A-1331852 were potent to kill melanoma ...
(A) Dose-response curves for the MCL-1 inhibitor S63845 and the BCL-XL ...
Trametinib and S63845 combination inhibits tumor growth in a PDX model ...
Synergistic cell death induction by venetoclax and S63845 in BCP-ALL ...
The MCL-1 inhibitor S63845 and VTX combine synergistically to reduce ...
S63845 induced apoptosis is mainly independent of BAK. (A) BAK was ...
Mcl1 inhibitor S63845 enhances apoptosis induced by treatment with ...
S63845 and VTX combine to induce apoptosis in SS cell lines. (A ...
Combined S63845 and S55746 did not affect normal hematopoietic cell ...
S63845 plus AZA treatment disrupts sphere formation. (A) Quantification ...
(PDF) BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 ...
Navitoclax, S63845, and venetoclax induce STING activation and the ...
The mtDNA-STING pathway plays an important role in both navitoclax- and ...
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor ...
Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor ...
BAK-dependent Eltro/S63845 synergy in Jurkat cells. a After treatment ...
Ulixertinib/S63845 co-treatment changes the expression of pro-and ...
Strong response of S63845-resistant cells to ABT-263 and ABT-737. CTCL ...
BAX and BAK are essential for S63845/venetoclax combination response ...
The paclitaxel/S63845 combination inhibits the growth of xenografts ...
MCL1抑制剂(S63845) – 960化工网
Cross-comparisons between S63845-sensitive and -resistant cell lines ...
(PDF) Shotgun Lipidomics Elucidates the Lipidome Alterations of the Mcl ...
S63845-mediated inhibition of MCL-1 activity is accompanied by ...
